Table of Contents
Commercialization Metrics
- Total commercial spending for pre-clinical, Phase I and Phase II
- Pre-clinical, Phase I and Phase II spending for each of the following
marketing categories and sub-categories
- Medical affairs
- Thought leader development
- Thought leader programs
- Medical education
- Medical information
- Decision support
- Market research
- Competitive intelligence
- Market access
- Pricing strategy and analysis
- Pharmacoeconomics
- Reimbursement
- Advertising and promotions
Brand Characteristics and Context
- Actual or projected launch dates for the US, Europe and Asia/Japan markets
- Global and US peak annual sales
- Number of years after launch that the drug is expected to reach global and
US peak annual sales
- Whether the drug is a first-in-class product
- Whether the drug is indicated for first-line treatment
- Therapeutic area
- Brand development timelines (in number of months) for pre-clinical, Phase
I and Phase II
|
Related Report
|
View Cart
